John J. Sramek - Concepedia

Author

John J. Sramek

Los Angeles Clinical Trials ORCID

Also Known As

J J Sramek, J Sramek, J Srámek, J. J. Sramek, J. Sramek, J. ŠRÁMEK, J. Šrámek, J.J. Sramek, JOHN J. SRAMEK, JOHN SRAMEK

174

Publications

4.9K

Citations

H-Index

107

Concepts

All Affiliations

Los Angeles Clinical Trials Norwalk Hospital University of California, Irvine

About

John J. Sramek is an author at Los Angeles Clinical Trials specializing in medicine, psychiatry, and pharmacology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	23	43	2.6K
2	Social Sciences	15	22	1.7K
3	Health Sciences	5	5	164
4	Anesthesia	1	1	45
5	Biochemistry	1	1	19

John J. Sramek

Publications

3.5K

Citations

H-Index

Page 1

	Year	Citations
Distinct Mechanism for Antidepressant Activity by Blockade of Central Substance P Receptors Mark S. Kramer, Neal R. Cutler, John P. Feighner, Science Psychotropic MedicationPsychopharmacologyAntidepressant ActivityPharmacotherapySubstance P Antagonists	1998	1.1K
A Randomized Evaluation of the Effects of Six Antipsychotic Agents on QTc, In the Absence and Presence of Metabolic Inhibition Edmund P. Harrigan, Jeffrey Miceli, Richard Anziano, Journal of Clinical Psychopharmacology Randomized EvaluationPsychoactive DrugMean Qtc IntervalsQtc ProlongationPsychiatry	2004	357
Sex differences in the psychopharmacological treatment of depression John J. Sramek, Michael Murphy, Neal R. Cutler Dialogues in Clinical Neuroscience	2016	326
Gender Differences in Depression and Antidepressant Pharmacokinetics and Adverse Events John J. Sramek, Neal R. Cutler Annals of Pharmacotherapy	2000	121
Cholinergic Rebound and Rapid Onset Psychosis Following Abrupt Clozapine Withdrawal Thomas Shiovitz, T. L. Welke, Phillip D. Tigel, Schizophrenia Bulletin	1996	102
Gender Differences in Depression and Antidepressant Pharmacokinetics and Adverse Events Edyta J. Frackiewicz, John J. Sramek, Neal R. Cutler Annals of Pharmacotherapy Depression PrevalencePsychotropic MedicationPsychopharmacologyPharmacotherapyMental Health	2000	91
Efficacy and safety of sibutramine for weight loss in obese patients with hypertension well controlled by β-adrenergic blocking agents: a placebo-controlled, double-blind, randomised trial John J. Sramek, Mark Leibowitz, Samuel Weinstein, Journal of Human Hypertension ObesityMetabolic SyndromeHypertensionWeight LossCardiovascular Disease	2002	79
Adverse Effects of Antipsychotic Agents George M. Simpson, Edmond H. Pi, John J. Sramek Drugs Psychoactive DrugPsychiatryMedicinePsychotropic MedicationPsychopharmacology	1981	73
High Potency Neuroleptics and Violence in Schizophrenics J Herrera, John J. Sramek, Jérôme Costa, The Journal of Nervous and Mental Disease Inpatient ViolenceNeuropsychologyPsychopharmacologyNeuropsychiatryPsychology	1988	64
An Open Trial of Glycine as an Adjunct to Neuroleptics in Chronic Treatment-Refractory Schizophrenics JEROME COSTA, Ebtesam Khaled, John J. Sramek, Journal of Clinical Psychopharmacology Psychotropic MedicationPsychopharmacologyNeuropsychiatryJerome MdPharmacotherapy	1990	55

Page 1